TY - JOUR
T1 - Adjustment disorder in cancer patients after treatment
T2 - prevalence and acceptance of psychological treatment
AU - van Beek, F. E.
AU - Wijnhoven, L. M. A.
AU - Custers, J. A. E.
AU - Holtmaat, K.
AU - de Rooij, B. H.
AU - Horevoorts, N. J. E.
AU - Aukema, E. J.
AU - Verheul, S.
AU - Eerenstein, S. E. J.
AU - Strobbe, L.
AU - van Oort, I. M.
AU - Vergeer, M. R.
AU - Prins, J. B.
AU - Verdonck-de Leeuw, I. M.
AU - Jansen, F.
N1 - Funding Information: This research is funded by ZonMw, The Netherlands Organization for Health [grant number: 856001005]. The funding source had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2022/2
Y1 - 2022/2
N2 - Purpose: To investigate the prevalence of adjustment disorder (AD) among cancer patients and the acceptance of psychological treatment, in relation to sociodemographic, clinical, and psychological factors. Methods: Breast, prostate, and head and neck cancer patients of all stages and treatment modalities (N = 200) participated in this observational study. Patients completed the Hospital Anxiety and Depression Scale, Checklist Individual Strength, Distress Thermometer and problem list. Patients with increased risk on AD based on these questionnaires were scheduled for a diagnostic interview. Patients diagnosed with AD were invited to participate in a randomized controlled trial on the cost-effectiveness of psychological treatment. Participation in this trial was used as a proxy of acceptance of psychological treatment. Logistic regression analyses were used to investigate associated factors. Results: The overall prevalence of AD was estimated at 13.1%. Sensitivity analyses showed prevalence rates of AD of 11.5%, 15.0%, and 23.5%. Acceptance of psychological treatment was estimated at 65%. AD was associated both with being employed (OR = 3.3, CI = 1.3–8.4) and having a shorter time since diagnosis (OR = 0.3, CI = 0.1–0.8). Conclusion: Taking sensitivity analysis into account, the prevalence of AD among cancer patients is estimated at 13 to 15%, and is related to being employed and having a shorter time since diagnosis. The majority of cancer patients with AD accept psychological treatment.
AB - Purpose: To investigate the prevalence of adjustment disorder (AD) among cancer patients and the acceptance of psychological treatment, in relation to sociodemographic, clinical, and psychological factors. Methods: Breast, prostate, and head and neck cancer patients of all stages and treatment modalities (N = 200) participated in this observational study. Patients completed the Hospital Anxiety and Depression Scale, Checklist Individual Strength, Distress Thermometer and problem list. Patients with increased risk on AD based on these questionnaires were scheduled for a diagnostic interview. Patients diagnosed with AD were invited to participate in a randomized controlled trial on the cost-effectiveness of psychological treatment. Participation in this trial was used as a proxy of acceptance of psychological treatment. Logistic regression analyses were used to investigate associated factors. Results: The overall prevalence of AD was estimated at 13.1%. Sensitivity analyses showed prevalence rates of AD of 11.5%, 15.0%, and 23.5%. Acceptance of psychological treatment was estimated at 65%. AD was associated both with being employed (OR = 3.3, CI = 1.3–8.4) and having a shorter time since diagnosis (OR = 0.3, CI = 0.1–0.8). Conclusion: Taking sensitivity analysis into account, the prevalence of AD among cancer patients is estimated at 13 to 15%, and is related to being employed and having a shorter time since diagnosis. The majority of cancer patients with AD accept psychological treatment.
KW - Acceptance of psychological treatment
KW - Adjustment disorder
KW - Cancer
KW - Prevalence
KW - Psychological treatment
KW - Psychology
UR - http://www.scopus.com/inward/record.url?scp=85116231871&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s00520-021-06530-0
DO - https://doi.org/10.1007/s00520-021-06530-0
M3 - Article
C2 - 34599663
SN - 0941-4355
VL - 30
SP - 1797
EP - 1806
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 2
ER -